North America Leads the Veterinary Ophthalmic Drugs Market Amid High Pet Ownership
North America has established itself as the dominant region in the global Veterinary Ophthalmic Drugs Market, driven by high pet ownership rates, advanced veterinary healthcare infrastructure, and strong consumer spending on pet health. The region accounted for a substantial share in 2024, valued at approximately USD 800 million, and is projected to reach USD 1.3 billion by 2035. The Veterinary...
0 Kommentare 0 Anteile 0 Vorschau